Alk-Amplified Circulating Tumor Cells As A Surrogate Marker For Crizotinib Benefit In Alk-Rearranged Non-Small Cell Lung Cancer Patients.
JOURNAL OF CLINICAL ONCOLOGY(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2016)